New

Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

›ETF Providers›ARK Invest Europe›ARXK

ARXK ETF · ARK Innovation UCITS ETF

The ARXK Exchange Traded Fund (ETF) is provided by ARK Invest Europe. This fund is actively managed; it does not track an index. The dividend policy is capitalization.
Real-time data unavailable for ARXK
LIVE
CLOSED
This fund is part ofWorld Blended Cap1M perf.-5.01%
Last price
N/A
1M perf.
-7.69%
1M flows
-€4.6M
AuM
€233M
E/R
0.75%
Rating
Not rated
ESG Consensus®
esg grade icon
ARXK
N/A

Performance & flows

Segment for quartile rank
January 2, 2026 → April 1, 2026
0-20-15-10-505%FEBMARAPRFEBMARAPR
Create a free account to view the flows graph
ARXK
$7.24
-11.58%
World Blended Cap
-0.90%

Historic performance and flows

1M3M1Y3Y5YMTDQTDYTD
Perf.
-7.69%
icon
-11.58%
icon
+46.36%
icon
N/AN/A
+1.27%
+1.27%
-9.93%
icon
Flows

Key fund info

Segment for quartile rank
Main characteristics
ISIN
IE000GA3D489
AuM
€233M
icon
E/R
0.75%
icon
ESG Consensus®
esg grade icon
icon
More details
NAV
4/1/2026
$7.24
1D NAV change
+1.27%
Dividend policy
No. of holdings
42
Inception date
4/12/2024
Jurisdiction
Ireland
Distribution
Luxembourg
Netherlands
Austria
Denmark
Finland
Legal structure
Irish Collective Asset-management Vehicle
Base currency
USD
Classification
Product type
Asset class
Factors
N/A
Investment strategy
ARK Innovation UCITS ETF is an actively managed exchange-traded fund incorporated in Ireland. The Fund will invest in equity securities of companies relevant to the theme of disruptive innovation. Relevant themes are those that reply on or benefit from the development of new products or services in scientific research relating to Genomics Revolution, Web x.0, and Industrial Innovation.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
half moonhalf moon double
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
See all Trackinsight Enterprise features

Trackinsight
Enterprise

Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight Enterprise

Similar ETFs

ARKK
1M perf.
-7.82%
E/R
0.75%

Advertisement

Risk profile

Segment for quartile rank

Historical risk/return profile

3M1Y3Y5Y
Returns
-11.58%
icon
+46.36%
icon
N/A
N/A
Volatility
Perf./Volatility
Max drawdown
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
1
2
3
4
5
6
7
PRIIPS
1
2
3
4
5
6
7
More exposure metrics are available, exclusively in Trackinsight Enterprise

Exposure

Countries
USA
86.42%
Switzerland
6.09%
Canada
5.34%
Cayman Islands
2.15%
Sectors
Health Care
26.11%
Information Technology
18.21%
Consumer Discretionary
11.10%
Communication Services
10.17%
Financials
8.95%
Industrials
4.75%
Energy
1.46%
Unavailable
19.25%
Diversification
Total weight of top 15 holdings out of 42
Top 15 holdings
Data as of February 28, 2026
TESLA
CRISPR THERAPEUTICS
ADVANCED MICRO DEVICES
US88023B1035
ROBINHOOD MARKETS
ROKU INC
BEAM THERAPEUTICS
SHOPIFY SUBORDINATE VOTING
Create a free account to view top holdings
COINBASE GLOBAL
TWIST BIOSCIENCE CORP
ROBLOX
10X GENOMICS INC
INTELLIA THERAPEUTICS INC
US1725731079
PALANTIR TECHNOLOGIES
Create a free account to view top holdings
More risk metrics are available, exclusively in Trackinsight Enterprise

Sustainability

Integrates ESG criteria
Yes
SDG
More sustainability metrics are available, exclusively in Trackinsight Enterprise

Issuer

ARK Invest Europe
ARK Invest Europe ID Card
Number of funds
10
Total AuM
€882M
Expense ratio range
0.45% - 0.75%
Average expense ratio
0.58%

The details about this provider will be added soon.

Frequently asked questions about ARXK

What does ARK Innovation UCITS ETF, ARXK, invest in?

ARXK is a Active ETF. This ETF provides exposure to Other Equities.

What is the Total Expense ratio (TER) of ARXK?

ARXK carries a total expense ratio (TER) of 0.75%, indicating the annual cost for holding the fund.

When was ARXK launched?

ARXK was introduced to the market on April 12, 2024. It trades on Luxembourg, among other exchanges

Who is the ETF issuer of ARXK?

ARK Innovation UCITS ETF, ARXK, is provided by ARK Invest Europe. Learn more about ARK Invest Europe here.

What is the current assets under management (AUM) of ARXK?

ARXK oversees €233M in assets as of April 1, 2026.

How has ARXK performed lately?

Based on data from April 1, 2026, ARXK returned -7.69% over the past month, -11.58% over the last three months and -9.93% year-to-date.

What are the latest inflows or outflows for ARXK?

As of April 1, 2026, ARXK recorded net flows of -€4.6M over the last month and -€33M year-to-date.

Does ARXK distribute dividends?

ARXK follows a capitalizing, meaning it reinvests income within the fund.

What are the main country or region exposures of ARXK?

As of February 28, 2026, ARXK has significant geographic allocations in USA, Switzerland and Canada.

In which sector or theme does ARXK invest in?

As of February 28, 2026, ARXK focuses largely on Health Care, Information Technology and Consumer Discretionary.

How many securities does ARXK hold and how diversified is it?

As of February 28, 2026, ARXK holds 42 positions in its portfolio, with 64.77% of assets concentrated in its top 15 holdings.

What are the main positions in ARXK?

As of February 28, 2026, ARXK top three holdings include TESLA, CRISPR THERAPEUTICS and ADVANCED MICRO DEVICES.

What is the base currency of ARXK?

The base currency of ARXK is USD.

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight